Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes-Reference-Cited by-同舟云学术

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes

Published:2020-12 Issue:5 Volume:1 Page:326-335
ISSN:2666-5018
Container-title:Heart Rhythm O2
language:en
Short-container-title:Heart Rhythm O2

Author:

Lambiase Pier D.,Eckardt Lars,Theuns Dominic A.,Betts Timothy R.,Kyriacou Andreas L.,Duffy Elizabeth,Knops Reinoud

Funder

Boston Scientific Corporation

Publisher

Elsevier BV

Subject

General Medicine,General Chemistry

Reference28 articles.

1. Long QT syndrome in children in the era of implantable defibrillators;Etheridge;J Am Coll Cardiol,2007

2. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications;Olde Nordkamp;Heart Rhythm,2016

3. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU);Rosso;Isr Med Assoc J,2008

4. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2;Sacher;Circulation,2013

5. Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation;Frommeyer;J Interv Card Electrophysiol,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry;Heart Rhythm;2024-04

2. Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies;Journal of Clinical Medicine;2024-03-20

3. More than 30 years of Brugada syndrome: a critical appraisal of achievements and open issues;Herzschrittmachertherapie + Elektrophysiologie;2023-12-12

4. Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease;Cardiac Electrophysiology Clinics;2023-12

5. Novelties in Brugada Syndrome: Complex Genetics, Risk Stratification, and Catheter Ablation;Cardiac Electrophysiology Clinics;2023-09